This regular feature presents special issues in oncologic pathology.
Introduction
Primary malignant tumors of the vagina are rare, representing only 1% to 2% of all malignancies of the female genital tract. 1 Of these, squamous cell carcinoma (SCC) is the most prevalent neoplasm, accounting for over 90% of vaginal tumors. 2 While papillary squamous cell carcinoma (PSCC) of the uterine cervix has been previously reported, 3 a papillary variant of primary vaginal SCC has not been described, to our knowledge, in the medical literature.
PSCC of the vagina should be differentiated from other benign and malignant papillary tumors of the vagina including fibroepithelial polyps, squamous papilloma, condyloma accuminatum, transitional carcinoma, transitional carcinoma with squamous differentiation, verrucous carcinoma, and botryoid rhabdomyosarcoma. The prognosis of the cervical counterpart of PSCC is similar to that of invasive SCC except for the high incidence of late recurrences in PSCC.
Case Report
A 49-year-old woman (para 4-0-2-2) presented with a complaint of postmenopausal vaginal bleeding.
Clinical examination revealed two vaginal polypoid lesions, 1.2 cm and 0.6 cm in largest diameter, located on the posterior and right vaginal wall, respectively. Both vaginal polyps were excised. Postoperative radioactive implant therapy was administered (two implants for a total of 62.83 Gy). The patient is doing well and is free of disease at the time of this report. A review of her medical records revealed a past history of cervical intraepithelial neoplasia for which she underwent hysterectomy in 1971. No invasive carcinoma was found in the hysterectomy specimen. Also, a previous vaginal lesion was diagnosed as "Bowen's disease" and treated with laser surgery in 1990. This lesion was not available for review.
Methods
Biopsy tissue sections were cut from 10% buffered formalin paraffin blocks. Serial 5-µm-thick sections were mounted on glass slides and stained with hematoxylin and eosin, as well as the following undiluted 
Results
Gross: The biopsy specimens were tan-white polypoid lesions measuring 1.5 cm and 1.1 cm in greatest dimension, respectively.
Histopathology:
The low-power microscopic examination revealed stratified squamous mucosa with a papillary neoplasm (Fig 1) .
The papillae were covered by several layers of basaloid cells with scant cytoplasm and hyperchromatic nuclei ( Fig 2) .
There were numerous mitoses and no maturation. Single-cell keratinization was noted focally (Fig 3) .
An invasive component was easily identified at the base of this papillary tumor. The invasive area was characterized by nonpapillary, non-keratinizing SCC growing in nests with vague peripheral palisading.
The invasive tumor was surrounded by a stromal desmoplastic reaction (Fig 4) .
Neither viral changes nor Bowen's disease was identified.
<P Immunohistochemistry: Immunostains for chromogranin, neuron-specific enolase, synaptophysin, and human papilloma virus were negative. The tumor cells were pancytokeratin (AE1/AE3)-positive but cytokeratin 20-negative ( Fig 5A) . Only focal areas of cytokeratin 7 immunoreactivity were identified ( Fig   5B) , away from the papillary component of the tumor. Positive and negative controls were appropriate.
Ultrastructural Features: The tumor cells were polygonal, with an increased nuclear-to-cytoplasmic ratio, and contained numerous desmosomes and cytoplasmic tonofilaments. Neither neurosecretory granules nor secretory granules were identified. Viral particles were not present.
Discussion
In 1986, Randall et al 3 In order to substantiate a claim of primary carcinoma of the vagina, local extension and metastatic disease must first be ruled out. 5, 6 Our patient underwent a hysterectomy 25 years prior to the identification of the vaginal lesions, making metastatic disease from an undocumented cervical PSCC highly unlikely.
In addition, the location of the polypoid growth observed grossly in our patient occurred within 3 cm of the introitus, well away from the historical surgical margin. Lastly, the metastatic disease workup in our patient consisted of colonoscopy, cystoscopy, abdominal and pelvic computed tomography, and hepatic ultrasound, all of which were negative. Given these facts and the accepted criteria that a patient must be free of vulvar and cervical cancer at the time of diagnosis and for a period of 10 years prior to diagnosis, 6 it is reasonable to conclude that our patient developed a primary vaginal PSCC.
Although this primary vaginal tumor was histologically identical to that described in cervical PSCC, careful consideration was given to other lesions in the differential diagnosis. Benign lesions such as transitional cell metaplasia were ruled out by the histological evidence of invasion. An exceedingly rare variant of SCC, with features similar to basal cell tumors of the skin, is the basaloid variant. 7 Papillary architecture, however, has not been described in this entity. Adenosquamous carcinoma of the vagina usually exhibits a mixture of squamous and glandular differentiation without papillary projections. 8, 9 Papillary projections would also be "unusual" in entities such as malignant melanoma, lymphoma, neuroendocrine tumors and sarcoma, except for a botryoid rhabdomyosarcoma.
The latter entity usually occurs in young patients and is histologically incompatible with the lesion described here. Immunohistochemical and ultrastructural findings eliminate these diagnostic considerations. focally and weakly positive for cytokeratin 7. Both of these markers are usually strongly positive in transitional cell carcinoma. [10] [11] [12] Cytokeratin 20 is also invariably negative in SCCs. 12 oncogenic human papilloma virus infection of the lower genital tract. The histologic, immunohistochemical, and ultrastructural features of this vaginal papillary lesion, however, lack evidence of a viral infection.
Clinically, our patient presented with vaginal bleeding, as did the majority of patients described by Randall et al. 3 Of their nine patients, three developed recurrent disease: one patient died of disseminated disease, and another died of concurrent duodenal adenocarcinoma. Despite these historical observations, generalization about prognosis and tumor behavior at the vaginal site will require the evaluation of additional cases. At the last follow-up in July of 1997, our patient was still free of disease.
